Initial interaction of rotavirus strains with N-acetylneuraminic (sialic) acid residues on the cell surface correlates with VP4 genotype, not species of origin.

PubWeight™: 1.42‹?› | Rank: Top 5%

🔗 View Article (PMC 136071)

Published in J Virol on April 01, 2002

Authors

Max Ciarlet1, Juan E Ludert, Miren Iturriza-Gómara, Ferdinando Liprandi, James J Gray, Ulrich Desselberger, Mary K Estes

Author Affiliations

1: Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas 77030, USA. mciarlet@bcm.tmc.edu

Articles citing this

The rhesus rotavirus VP4 sialic acid binding domain has a galectin fold with a novel carbohydrate binding site. EMBO J (2002) 2.41

Integrin-using rotaviruses bind alpha2beta1 integrin alpha2 I domain via VP4 DGE sequence and recognize alphaXbeta2 and alphaVbeta3 by using VP7 during cell entry. J Virol (2003) 1.56

Spike protein VP8* of human rotavirus recognizes histo-blood group antigens in a type-specific manner. J Virol (2012) 1.38

Sialic acid dependence in rotavirus host cell invasion. Nat Chem Biol (2008) 1.31

Role of sialic acids in rotavirus infection. Glycoconj J (2006) 1.28

Viruses and sialic acids: rules of engagement. Curr Opin Struct Biol (2011) 1.21

Rotavirus VP8*: phylogeny, host range, and interaction with histo-blood group antigens. J Virol (2012) 1.18

High-resolution molecular and antigen structure of the VP8* core of a sialic acid-independent human rotavirus strain. J Virol (2006) 1.16

Requirement for vacuolar H+ -ATPase activity and Ca2+ gradient during entry of rotavirus into MA104 cells. J Virol (2002) 1.14

A rotavirus spike protein conformational intermediate binds lipid bilayers. J Virol (2009) 1.10

Alternative intermolecular contacts underlie the rotavirus VP5* two- to three-fold rearrangement. EMBO J (2006) 1.06

Specificity and affinity of sialic acid binding by the rhesus rotavirus VP8* core. J Virol (2002) 1.06

Different rotavirus strains enter MA104 cells through different endocytic pathways: the role of clathrin-mediated endocytosis. J Virol (2010) 1.06

Rhesus rotavirus entry into a polarized epithelium is endocytosis dependent and involves sequential VP4 conformational changes. J Virol (2010) 1.00

Monkey rotavirus binding to alpha2beta1 integrin requires the alpha2 I domain and is facilitated by the homologous beta1 subunit. J Virol (2003) 0.93

Effects on rotavirus cell binding and infection of monomeric and polymeric peptides containing alpha2beta1 and alphaxbeta2 integrin ligand sequences. J Virol (2004) 0.91

Poly-LacNAc as an age-specific ligand for rotavirus P[11] in neonates and infants. PLoS One (2013) 0.91

The spike protein VP4 defines the endocytic pathway used by rotavirus to enter MA104 cells. J Virol (2012) 0.91

Rotaviruses reach late endosomes and require the cation-dependent mannose-6-phosphate receptor and the activity of cathepsin proteases to enter the cell. J Virol (2014) 0.88

Structural basis of rotavirus strain preference toward N-acetyl- or N-glycolylneuraminic acid-containing receptors. J Virol (2012) 0.85

Cloning, expression, purification, crystallization and preliminary X-ray diffraction analysis of the VP8* carbohydrate-binding protein of the human rotavirus strain Wa. Acta Crystallogr Sect F Struct Biol Cryst Commun (2005) 0.83

Characterization of neuraminidase-resistant mutants derived from rotavirus porcine strain OSU. J Virol (2005) 0.79

Relative roles of GM1 ganglioside, N-acylneuraminic acids, and α2β1 integrin in mediating rotavirus infection. J Virol (2014) 0.79

Complete genome characterization of recent and ancient Belgian pig group A rotaviruses and assessment of their evolutionary relationship with human rotaviruses. J Virol (2014) 0.79

'Sialidase sensitivity' of rotaviruses revisited. Nat Chem Biol (2009) 0.77

Inhibitory Effect of a Hot-Water Extract of Leaves of Japanese Big-Leaf Magnolia (Magnolia obovata) on Rotavirus-Induced Diarrhea in Mouse Pups. Evid Based Complement Alternat Med (2014) 0.75

Glycan Specificity of P[19] Rotavirus and Comparison with Those of Related P Genotypes. J Virol (2016) 0.75

Expression, purification, crystallization and preliminary X-ray diffraction analysis of the VP8* sialic acid-binding domain of porcine rotavirus strain OSU. Acta Crystallogr Sect F Struct Biol Cryst Commun (2007) 0.75

Diversity in Rotavirus-Host Glycan Interactions: A "Sweet" Spectrum. Cell Mol Gastroenterol Hepatol (2016) 0.75

Articles cited by this

Identification of the rotaviral gene that codes for hemagglutination and protease-enhanced plaque formation. Virology (1983) 5.13

Proteolytic enhancement of rotavirus infectivity: molecular mechanisms. J Virol (1981) 4.87

Gene coding assignments for growth restriction, neutralization and subgroup specificities of the W and DS-1 strains of human rotavirus. J Gen Virol (1983) 4.25

Structural polypeptides of simian rotavirus SA11 and the effect of trypsin. J Virol (1981) 3.27

Molecular basis of rotavirus virulence: role of gene segment 4. J Virol (1986) 3.08

Reassortant rotaviruses as potential live rotavirus vaccine candidates. J Virol (1985) 2.95

Characterization of virus-like particles produced by the expression of rotavirus capsid proteins in insect cells. J Virol (1994) 2.48

The VP8 fragment of VP4 is the rhesus rotavirus hemagglutinin. Virology (1991) 1.92

Human and most animal rotavirus strains do not require the presence of sialic acid on the cell surface for efficient infectivity. J Gen Virol (1999) 1.73

Comparison of human, simian, and bovine rotaviruses for requirement of sialic acid in hemagglutination and cell adsorption. Virology (1989) 1.71

Single gene substitution rotavirus reassortants containing the major neutralization protein (VP7) of human rotavirus serotype 4. J Clin Microbiol (1986) 1.70

Genetic mapping indicates that VP4 is the rotavirus cell attachment protein in vitro and in vivo. J Virol (1996) 1.56

Glycosphingolipid binding specificities of rotavirus: identification of a sialic acid-binding epitope. J Virol (2001) 1.51

Binding to sialic acids is not an essential step for the entry of animal rotaviruses to epithelial cells in culture. J Virol (1993) 1.50

Proteolysis of monomeric recombinant rotavirus VP4 yields an oligomeric VP5* core. J Virol (2001) 1.33

Ganglioside GM(1a) on the cell surface is involved in the infection by human rotavirus KUN and MO strains. J Biochem (1999) 1.27

Entry of rotaviruses is a multistep process. Virology (1999) 1.25

Interactions between the two surface proteins of rotavirus may alter the receptor-binding specificity of the virus. J Virol (1996) 1.22

Differential infection of polarized epithelial cell lines by sialic acid-dependent and sialic acid-independent rotavirus strains. J Virol (2001) 1.19

Characterization of the sialic acid binding activity of transmissible gastroenteritis coronavirus by analysis of haemagglutination-deficient mutants. J Gen Virol (2000) 1.18

The VP5 domain of VP4 can mediate attachment of rotaviruses to cells. J Virol (2000) 1.16

Gangliosides as binding sites in SA-11 rotavirus infection of LLC-MK2 cells. J Gen Virol (1991) 1.16

Assay for evaluation of rotavirus-cell interactions: identification of an enterocyte ganglioside fraction that mediates group A porcine rotavirus recognition. J Virol (1994) 1.09

Identification of a new VP4 serotype of human rotaviruses. Virology (1994) 1.07

Sequence analysis of two porcine rotaviruses differing in growth in vitro and in pathogenicity: distinct VP4 sequences and conservation of NS53, VP6 and VP7 genes. J Gen Virol (1994) 1.06

Productive penetration of rotavirus in cultured cells induces coentry of the translation inhibitor alpha-sarcin. Virology (1997) 1.05

Interactions between rotavirus and gastrointestinal cells. Curr Opin Microbiol (2001) 1.04

Functional and structural analysis of the sialic acid-binding domain of rotaviruses. J Virol (1997) 1.02

Rotavirus infection of MA104 cells is inhibited by Ricinus lectin and separately expressed single binding domains. Virology (2000) 1.01

Production and characterization of murine IgA monoclonal antibodies to the surface antigens of rhesus rotavirus. Virology (1996) 0.95

Human rotavirus HCR3 possesses a genomic RNA constellation indistinguishable from that of feline and canine rotaviruses. Arch Virol (2000) 0.94

Species specificity and interspecies relatedness in VP4 genotypes demonstrated by VP4 sequence analysis of equine, feline, and canine rotavirus strains. Virology (1994) 0.94

Identification of mutations in the rotavirus protein VP4 that alter sialic-acid-dependent infection. J Gen Virol (1998) 0.92

Viral determinants of rotavirus pathogenicity in pigs: production of reassortants by asynchronous coinfection. J Virol (1997) 0.89

Viral determinants of rotavirus pathogenicity in pigs: evidence that the fourth gene of a porcine rotavirus confers diarrhea in the homologous host. J Virol (1998) 0.87

Attenuated murine cytomegalovirus binds to N-acetylglucosamine, and shift to virulence may involve recognition of sialic acids. J Virol (1990) 0.87

Biological properties of mengovirus: characterization of avirulent, hemagglutination-defective mutants. Arch Virol (1987) 0.83

Haemagglutination by rotaviruses in relation to VP4 genotypes. Res Virol (1996) 0.82

Articles by these authors

Norovirus gastroenteritis. N Engl J Med (2009) 7.66

Norwalk virus infection and disease is associated with ABO histo-blood group type. J Infect Dis (2002) 5.09

Laboratory efforts to cultivate noroviruses. J Gen Virol (2004) 4.41

Uniformity of rotavirus strain nomenclature proposed by the Rotavirus Classification Working Group (RCWG). Arch Virol (2011) 3.87

Norovirus vaccine against experimental human Norwalk Virus illness. N Engl J Med (2011) 3.78

Full genome-based classification of rotaviruses reveals a common origin between human Wa-Like and porcine rotavirus strains and human DS-1-like and bovine rotavirus strains. J Virol (2008) 3.73

Norwalk virus shedding after experimental human infection. Emerg Infect Dis (2008) 3.70

Norwalk virus-like particle hemagglutination by binding to h histo-blood group antigens. J Virol (2003) 3.15

Norovirus disease: changing epidemiology and host susceptibility factors. Trends Microbiol (2004) 2.83

Recommendations for the classification of group A rotaviruses using all 11 genomic RNA segments. Arch Virol (2008) 2.77

Atomic resolution structural characterization of recognition of histo-blood group antigens by Norwalk virus. Proc Natl Acad Sci U S A (2008) 2.54

Rotavirus antigenaemia and viraemia: a common event? Lancet (2003) 2.51

Determination of the 50% human infectious dose for Norwalk virus. J Infect Dis (2013) 2.50

The epidemiologic and clinical importance of norovirus infection. Gastroenterol Clin North Am (2006) 2.49

The 3' end of Norwalk virus mRNA contains determinants that regulate the expression and stability of the viral capsid protein VP1: a novel function for the VP2 protein. J Virol (2003) 2.38

Structural requirements for the assembly of Norwalk virus-like particles. J Virol (2002) 2.38

Norwalk virus infection associates with secretor status genotyped from sera. J Med Virol (2005) 2.34

Molecular characterization of VP6 genes of human rotavirus isolates: correlation of genogroups with subgroups and evidence of independent segregation. J Virol (2002) 2.27

Serological correlate of protection against norovirus-induced gastroenteritis. J Infect Dis (2010) 2.21

Rice-based oral antibody fragment prophylaxis and therapy against rotavirus infection. J Clin Invest (2013) 2.15

Evolutionary history and global spread of the emerging g12 human rotaviruses. J Virol (2006) 2.12

X-ray structure of a native calicivirus: structural insights into antigenic diversity and host specificity. Proc Natl Acad Sci U S A (2006) 2.09

Rotaviruses: from pathogenesis to vaccination. Gastroenterology (2009) 2.05

Protective effect of natural rotavirus infection in an Indian birth cohort. N Engl J Med (2011) 2.04

Viral load in patients infected with dengue is modulated by the presence of anti-dengue IgM antibodies. J Clin Virol (2013) 2.01

Humoral, mucosal, and cellular immune responses to oral Norwalk virus-like particles in volunteers. Clin Immunol (2003) 1.89

Neonatal infection with G10P[11] rotavirus did not confer protection against subsequent rotavirus infection in a community cohort in Vellore, South India. J Infect Dis (2007) 1.83

Diversity and evolution of the envelope gene of dengue virus type 1. Virology (2002) 1.80

Inter- and intragenus structural variations in caliciviruses and their functional implications. J Virol (2004) 1.79

VP6-sequence-based cutoff values as a criterion for rotavirus species demarcation. Arch Virol (2012) 1.78

Human caliciviruses in symptomatic and asymptomatic infections in children in Vellore, South India. J Med Virol (2007) 1.76

Evolutionary trace residues in noroviruses: importance in receptor binding, antigenicity, virion assembly, and strain diversity. J Virol (2005) 1.71

Norwalk virus RNA is infectious in mammalian cells. J Virol (2007) 1.66

Cell attachment protein VP8* of a human rotavirus specifically interacts with A-type histo-blood group antigen. Nature (2012) 1.65

Norwalk virus-specific binding to oyster digestive tissues. Emerg Infect Dis (2006) 1.63

Analysis of amino acid variation in the P2 domain of the GII-4 norovirus VP1 protein reveals putative variant-specific epitopes. PLoS One (2008) 1.61

Replication and packaging of Norwalk virus RNA in cultured mammalian cells. Proc Natl Acad Sci U S A (2005) 1.56

Nosocomial rotavirus infection in European countries: a review of the epidemiology, severity and economic burden of hospital-acquired rotavirus disease. Pediatr Infect Dis J (2006) 1.54

Identification of Genogroup I and Genogroup II broadly reactive epitopes on the norovirus capsid. J Virol (2005) 1.53

Structural analysis of histo-blood group antigen binding specificity in a norovirus GII.4 epidemic variant: implications for epochal evolution. J Virol (2011) 1.53

Comparative study of the epidemiology of rotavirus in children from a community-based birth cohort and a hospital in South India. J Clin Microbiol (2006) 1.51

Epidemiology of human noroviruses and updates on vaccine development. Curr Opin Gastroenterol (2014) 1.49

Rotavirus architecture at subnanometer resolution. J Virol (2008) 1.48

Transmission events within outbreaks of gastroenteritis determined through analysis of nucleotide sequences of the P2 domain of genogroup II noroviruses. J Clin Microbiol (2008) 1.43

Seroepidemiology of norovirus-associated travelers' diarrhea. J Travel Med (2014) 1.43

Rotavirus viremia and extraintestinal viral infection in the neonatal rat model. J Virol (2006) 1.43

Vaccine-acquired rotavirus in infants with severe combined immunodeficiency. N Engl J Med (2010) 1.43

Incidence and risk factors of paediatric rotavirus diarrhoea in northern Ghana. Trop Med Int Health (2003) 1.42

Intussusception among young children in Europe. Pediatr Infect Dis J (2006) 1.42

Changes in causes of acute gastroenteritis in the United Kingdom over 15 years: microbiologic findings from 2 prospective, population-based studies of infectious intestinal disease. Clin Infect Dis (2012) 1.41

Characterization of G10P[11] rotaviruses causing acute gastroenteritis in neonates and infants in Vellore, India. J Clin Microbiol (2004) 1.41

Cross-reactivity among several recombinant calicivirus virus-like particles (VLPs) with monoclonal antibodies obtained from mice immunized orally with one type of VLP. J Clin Microbiol (2002) 1.40

Burden of illness in the first 3 years of life in an Indian slum. J Trop Pediatr (2009) 1.40

Norwalk virus does not replicate in human macrophages or dendritic cells derived from the peripheral blood of susceptible humans. Virology (2010) 1.40

Characterisation of a GII-4 norovirus variant-specific surface-exposed site involved in antibody binding. Virol J (2009) 1.39

Methods for determining disease burden and calibrating national surveillance data in the United Kingdom: the second study of infectious intestinal disease in the community (IID2 study). BMC Med Res Methodol (2010) 1.38

X-ray crystallographic structure of the Norwalk virus protease at 1.5-A resolution. J Virol (2006) 1.37

Evaluation of dengue NS1 antigen detection tests with acute sera from patients infected with dengue virus in Venezuela. Diagn Microbiol Infect Dis (2009) 1.35

Proinflammatory factors present in sera from patients with acute dengue infection induce activation and apoptosis of human microvascular endothelial cells: possible role of TNF-alpha in endothelial cell damage in dengue. Cytokine (2005) 1.33

Antibody prevalence and titer to norovirus (genogroup II) correlate with secretor (FUT2) but not with ABO phenotype or Lewis (FUT3) genotype. J Infect Dis (2006) 1.32

Autophagy hijacked through viroporin-activated calcium/calmodulin-dependent kinase kinase-β signaling is required for rotavirus replication. Proc Natl Acad Sci U S A (2012) 1.30

Stem cell-derived human intestinal organoids as an infection model for rotaviruses. MBio (2012) 1.27

Norwalk virus assembly and stability monitored by mass spectrometry. Mol Cell Proteomics (2010) 1.26

Relationships among porcine and human P[6] rotaviruses: evidence that the different human P[6] lineages have originated from multiple interspecies transmission events. Virology (2005) 1.24

Rotaviruses associate with cellular lipid droplet components to replicate in viroplasms, and compounds disrupting or blocking lipid droplets inhibit viroplasm formation and viral replication. J Virol (2010) 1.24

New oligonucleotide primers for P-typing of rotavirus strains: Strategies for typing previously untypeable strains. J Clin Virol (2008) 1.23

Lack of norovirus replication and histo-blood group antigen expression in 3-dimensional intestinal epithelial cells. Emerg Infect Dis (2013) 1.23

Serological responses to experimental Norwalk virus infection measured using a quantitative duplex time-resolved fluorescence immunoassay. Clin Vaccine Immunol (2011) 1.20

Cryoelectron microscopy structures of rotavirus NSP2-NSP5 and NSP2-RNA complexes: implications for genome replication. J Virol (2006) 1.20

Integrins alpha1beta1 and alpha2beta1 are receptors for the rotavirus enterotoxin. Proc Natl Acad Sci U S A (2008) 1.15

Norwalk Virus Minor Capsid Protein VP2 Associates within the VP1 Shell Domain. J Virol (2013) 1.15

Tracking the transmission routes of genogroup II noroviruses in suspected food-borne or environmental outbreaks of gastroenteritis through sequence analysis of the P2 domain. J Med Virol (2009) 1.13

Rotavirus disrupts calcium homeostasis by NSP4 viroporin activity. MBio (2010) 1.13

A novel type of VP4 carried by a porcine rotavirus strain. Virology (2003) 1.11

Group A rotavirus infection and age-dependent diarrheal disease in rats: a new animal model to study the pathophysiology of rotavirus infection. J Virol (2002) 1.10

Serum hemagglutination inhibition activity correlates with protection from gastroenteritis in persons infected with Norwalk virus. Clin Vaccine Immunol (2011) 1.10

VLA-2 (alpha2beta1) integrin promotes rotavirus entry into cells but is not necessary for rotavirus attachment. J Virol (2002) 1.10

Golgi localization of ERManI defines spatial separation of the mammalian glycoprotein quality control system. Mol Biol Cell (2011) 1.08

Immunogenicity and protective efficacy of rotavirus 2/6-virus-like particles produced by a dual baculovirus expression vector and administered intramuscularly, intranasally, or orally to mice. Vaccine (2003) 1.08

Tomato is a highly effective vehicle for expression and oral immunization with Norwalk virus capsid protein. Plant Biotechnol J (2006) 1.07

Inhibition of cellular protein secretion by norwalk virus nonstructural protein p22 requires a mimic of an endoplasmic reticulum export signal. PLoS One (2010) 1.07

Evidence for genetic linkage between the gene segments encoding NSP4 and VP6 proteins in common and reassortant human rotavirus strains. J Clin Microbiol (2003) 1.06

Norovirus vaccine development: next steps. Expert Rev Vaccines (2012) 1.03

Genomic analysis of codon, sequence and structural conservation with selective biochemical-structure mapping reveals highly conserved and dynamic structures in rotavirus RNAs with potential cis-acting functions. Nucleic Acids Res (2010) 1.02

Dissecting rotavirus particle-raft interaction with small interfering RNAs: insights into rotavirus transit through the secretory pathway. J Virol (2006) 1.01

The VP7 outer capsid protein of rotavirus induces polyclonal B-cell activation. J Virol (2004) 1.01

Host, viral, and vaccine factors that determine protective efficacy induced by rotavirus and virus-like particles (VLPs). Vaccine (2005) 1.01

The media's representation of the ideal male body: a cause for muscle dysmorphia? Int J Eat Disord (2002) 1.00

Rotavirus non-structural proteins: structure and function. Curr Opin Virol (2012) 0.99